# Assessment of Progranulin and FAM19A5 Protein Blood Levels in Metabolic Syndrome

> **NCT04451616** · — · UNKNOWN · sponsor: **Poznan University of Medical Sciences** · enrollment: 80 (estimated)

## Conditions studied

- Nutrition Disorders
- Hypertension
- Dyslipidemias
- Glucose Intolerance
- Glucose Metabolism Disorders
- Obesity
- Overweight and Obesity
- Metabolic Syndrome

## Interventions

- **DIAGNOSTIC_TEST:** Blood sample collection
- **DIAGNOSTIC_TEST:** Hair sample collection
- **DIAGNOSTIC_TEST:** Urine sample collection
- **DIAGNOSTIC_TEST:** Body composition analysis
- **DIAGNOSTIC_TEST:** Questionnaires
- **DIAGNOSTIC_TEST:** Blood pressure, pulse and blood oxygen saturation measurement

## Key facts

- **NCT ID:** NCT04451616
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-03
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04451616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04451616, "Assessment of Progranulin and FAM19A5 Protein Blood Levels in Metabolic Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04451616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*